The CF Foundation recently provided an update on the following research trial.
Study of N91115 in people with cystic fibrosis ages 18 and older with two copies of F508del-CFTR mutation
This Phase 1b, multi-center trial will assess the safety of N91115 and will look at how the body processes the drug – how it absorbs, breaks down, and gets rid of the drug.
This trial is for people ages 18 years and older who have two copies of the F508del-CFTR mutation. The trial is expected to last approximately one month. The study involves a physical exam, blood draws, lung function testing and other assessments.
- CFF Link: https://tools.cff.org/Display/dsp_ClinicalResearchHTML.cfm?id=388&IDH=9233791
- ClinicalTrials.gov Link: https://www.clinicaltrials.gov/ct2/show/NCT02275936